04935nam 2201417z- 450 991055734590332120220111(CKB)5400000000042431(oapen)https://directory.doabooks.org/handle/20.500.12854/76517(oapen)doab76517(EXLCZ)99540000000004243120202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierPrevention and Treatment of SarcopeniaBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 online resource (288 p.)3-0365-1536-4 3-0365-1535-6 Sarcopenia represents the decline in skeletal muscle mass and function with age, characterized by the muscle fiber's quality, strength, muscle endurance, and metabolic ability decreasing, as well as the fat and connective tissue growing.Reduction of muscle strength with aging leads to loss of functional capacity, causing disability, mortality, and other adverse health outcomes. Because of the increase of the proportion of elderly in the population, sarcopenia-related morbidity will become an increasing area of health care resource utilization.Diagnostic screening consists of individuation of body composition, assessed by DEXA, anthropometry, bioelectrical impedance, MRI, or CT scan. Management is possible with resistance training exercise and vibration therapy, nutritional supplements, and pharmacological treatment.The book includes articles from different nationalities, treating the experimental and medical applications of sarcopenia. The consequences of sarcopenia in frailty are treated in relation to other associated pathologies or lesions, as femoral neck fractures and hepatocellular carcinoma.Medicinebicsscaccelerometeraerobic exercise trainingagedageing fracturesaginganxietyapoptosisbalancebisphosphonatebrain-body cross-talkclinicalcognitioncomplicationsdeconditioningdecorindepressiondiagnosisdiagnostic criteriadual-energy X-ray absorptiometryechogenicityelderlyelectrical stimulationenduranceepidemiologic studiesexerciseexercise interventionfall riskfallsfatiguefracturesfrailtyhepatomahip fracturehospitalized older patientshypertrophyinsomniaisokinetic dynamometrylipidsmitochondriamotivationmultimorbiditymuscle massmuscle qualitymuscle regulatory factorsmuscle strengthmuscle-massmyokinenutritional screening toolsnutritional statusnutritional supplementsolder adultsolder personsosteoporosisoxidative stresspanoramic ultrasoundphysical activityphysical functional performancephysical therapypolypathological patientspostmenopausal womenprevalencepreventionprotein intakequality of liferandomized controlled trialrecoveryrehabilitationresistance exerciseresistance exercise trainingresistance trainingrespiratory systemsarcopeniasedentary behaviourskeletal muscleskeletal musclessleep durationsleep efficiencysleep qualityspecific forcespirometrystrengthsurvivaltelomere lengthtransaminasestreatmenttype 2 diabetesureavibrationwalking distanceβ-hydroxy-β-methylbutyrateMedicineTesta Gianlucaedt1290179Testa GianlucaothBOOK9910557345903321Prevention and Treatment of Sarcopenia3021394UNINA